Spire Healthcare Group plc
SPI.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.77 | -1.85 | -1.76 | 0.77 |
| FCF Yield | 7.36% | 7.23% | 5.27% | 7.02% |
| EV / EBITDA | 20.08 | 20.40 | 16.87 | 18.56 |
| Quality | ||||
| ROIC | 1.93% | 2.39% | 2.02% | 2.72% |
| Gross Margin | 45.34% | 45.08% | 38.07% | 45.42% |
| Cash Conversion Ratio | 18.18 | 10.31 | 7.57 | 7.98 |
| Growth | ||||
| Revenue 3-Year CAGR | 14.98% | 14.73% | 13.98% | 10.18% |
| Free Cash Flow Growth | 1.67% | 32.06% | -23.82% | 16.34% |
| Safety | ||||
| Net Debt / EBITDA | 11.70 | 11.75 | 9.46 | 10.47 |
| Interest Coverage | 1.20 | 1.34 | 1.37 | 1.27 |
| Efficiency | ||||
| Inventory Turnover | 9.47 | 8.82 | 10.38 | 8.41 |
| Cash Conversion Cycle | 3.10 | 4.28 | 7.92 | 8.41 |